Xolair
NDC 50242-227, omalizumab, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-227
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103976
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-227 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMALIZUMAB300 mg/2mL
Pharmacologic classes
Anti-IgE [EPC]; Decreased IgE Activity [PE]; IgE-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-227-01 | 50242022701 | 1 SYRINGE, GLASS in 1 CARTON (50242-227-01) / 2 mL in 1 SYRINGE, GLASS |
| 50242-227-55 | 50242022755 | 1 SYRINGE, GLASS in 1 CARTON (50242-227-55) / 2 mL in 1 SYRINGE, GLASS |
| 50242-227-86 | 50242022786 | 1 SYRINGE, GLASS in 1 CARTON (50242-227-86) / 2 mL in 1 SYRINGE, GLASS |
| 50242-227-99 | 50242022799 | 1 SYRINGE, GLASS in 1 CARTON (50242-227-99) / 2 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7f6a2191-adfb-48b9-9bfa-0d9920479f0dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-227
Use it
Look up 50242-227 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-227 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-227. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.